about
Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell ResponsesEstablishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon ReceptorRecall T cell responses to bluetongue virus produce a narrowing of the T cell repertoireImmunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10.New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccinesBiochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus.Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep.A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs.Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.Follicular dendritic cell disruption as a novel mechanism of virus-induced immunosuppressionArenavirus genetic diversity and its biological implications.Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV.A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice.IL-10: A Multifunctional Cytokine in Viral Infections.Ribavirin can be mutagenic for arenaviruses.Interleukin 8 and CK-6 chemokines specifically attract rainbow trout (Oncorhynchus mykiss) RTS11 monocyte-macrophage cells and have variable effects on their immune functions.Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice.Type I interferon limits the capacity of bluetongue virus to infect hematopoietic precursors and dendritic cells in vitro and in vivo.Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection.T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus.Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus.Predominant fusion of bone marrow-derived cardiomyocytes.Bovine Herpesvirus-4-Based Vector Delivering Peste des Petits Ruminants Virus Hemagglutinin ORF Induces both Neutralizing Antibodies and Cytotoxic T Cell ResponsesAltered lymphocyte homeostasis after oral prion infection in mouseA virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface bindingPeste des Petits Ruminants Virus Fusion and Hemagglutinin Proteins Trigger Antibody-Dependent Cell-Mediated Cytotoxicity in Infected CellsDiagnosing bluetongue virus in domestic ruminants: current perspectivesCK12, a rainbow trout chemokine with lymphocyte chemo-attractant capacity associated to mucosal tissuesVirus-induced autophagic degradation of STAT2 as a mechanism for interferon signaling blockade
P50
Q27340815-D8101711-F81C-49ED-8ECC-8D54979E6BA5Q27488281-CF6FCB6D-79FE-4B4C-8F30-2E073765FCF3Q32178442-9B3FE299-72CB-40C1-B2DF-60D709D236E7Q33455473-FC02141C-9D5F-4699-8607-1D0A3F74752FQ33573531-B2430D37-72FD-4A64-8651-B96E27B22331Q33744131-5B3E0645-70F5-4EB8-AB8F-BF97FEBEE793Q33889779-409B1A88-D98C-41D2-935A-C78D907F64D0Q34615916-D3052E72-7305-4853-AD0A-89440745BF74Q36380021-F0B6C9DB-3DA0-4923-B4F6-128233AA26A3Q37346805-FF5F531D-6953-4152-A521-EAC801849290Q37491440-78861C00-D093-4F86-A89E-306D1F86102DQ37716789-6D2CAADC-5C5D-4246-87A1-788E10F53259Q37866385-190DF9F8-57EF-463F-9995-89E4583C72DBQ39057140-D43716C3-9D7A-46FA-B915-91F87285161DQ39063204-A1E326B1-5CE7-4556-B483-2B64698229ECQ39186731-037FCE23-8155-4D9F-8223-0B32B79DA8C5Q39544616-F2BD716F-5210-4570-AA4C-01F9457B6F87Q39969313-869C4677-24C3-46A1-966E-73B6B3749807Q40468573-D9AECE01-D63E-470D-8502-4B271CC907F0Q41909022-621D0B70-75C6-4AD7-AE16-A81894B4CDCAQ45324559-FD9DC9C1-2A98-455B-A538-008303CC5F92Q45364496-EA3FD594-EC4B-4B88-80AE-CA9CA369CD43Q45616527-AC505518-4E09-4DBF-A4BE-65AD9F6787C4Q45766353-D7845D18-9D3E-46F0-ADBC-915F325D895CQ46220464-BC244CB1-A908-41BA-A241-48269EFA3248Q56902462-0381B401-7A87-4E9B-B05E-59E88C8448ADQ57261117-EE437D1E-FD36-45DB-8E35-6946AB4B5CB7Q60300348-A7D000EB-44EA-41A0-BF9F-84ED2B3E2719Q61448749-E203A897-6D28-49BB-923C-6A21DC67103FQ64271377-B221F400-9BDF-4230-820D-8FC7714B6457Q83572374-A639BFC1-E0F6-4AEF-95F5-D3BE41F9ECA3Q90650564-26AAD516-C0A9-4132-8C2A-BE529D029803
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Noemí Sevilla
@ast
Noemí Sevilla
@en
Noemí Sevilla
@es
Noemí Sevilla
@nl
Noemí Sevilla
@sl
type
label
Noemí Sevilla
@ast
Noemí Sevilla
@en
Noemí Sevilla
@es
Noemí Sevilla
@nl
Noemí Sevilla
@sl
prefLabel
Noemí Sevilla
@ast
Noemí Sevilla
@en
Noemí Sevilla
@es
Noemí Sevilla
@nl
Noemí Sevilla
@sl
P1053
K-8648-2014
P106
P21
P2798
P31
P3829
P496
0000-0003-0118-0376